HDAC8 Knockout Ca Ski Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population derived from the human Ca Ski cervical carcinoma cell line, generated through targeted disruption of the HDAC8 gene. This loss-of-function model enables investigation of histone deacetylase 8 (HDAC8) in a biologically relevant epithelial context, providing a powerful tool for dissecting epigenetic regulatory mechanisms and oncogenic signaling pathways. The polyclonal format preserves population heterogeneity, facilitating studies that require a broad representation of gene-edited phenotypes without clonal selection artifacts.
The parental Ca Ski cell line is a widely utilized human epithelial model originating from a cervical epidermoid carcinoma metastasis. It is characterized by stable integration of human papillomavirus type 16 (HPV16) genomic sequences, resulting in constitutive expression of the E6 and E7 viral oncoproteins. These oncoproteins disrupt p53 and retinoblastoma tumor suppressor pathways, rendering the cells particularly suitable for exploring interactions between viral oncogenesis and host epigenetic regulators like HDAC8 in cervical cancer progression.
HDAC8 functions as a class I histone deacetylase that catalyzes the removal of acetyl groups from lysine residues on histone and non-histone proteins, thereby promoting chromatin condensation and transcriptional repression. Its activity is regulated by upstream signals including the cAMP/PKA pathway, STAT3, and PKD1. Key downstream targets include Histone H3, Histone H4, p53, HSP70, cortactin, and ERR??, while it interacts with transcriptional corepressor complexes containing SMRT and NCoR. Through deacetylation of p53 and HSP70, HDAC8 modulates apoptosis and stress responses, contributing to the maintenance of transformed phenotypes.
In the context of Ca Ski cells, HDAC8 knockout is particularly significant due to the interplay between HDAC8-mediated deacetylation and HPV16-driven oncogenesis. The E6-mediated degradation of p53 may be influenced by HDAC8-dependent acetylation status of p53, while HDAC8 can also impact cortactin stability and cell migration, processes implicated in metastatic spread. Disruption of HDAC8 in this model provides a refined platform to evaluate how epigenetic modifications intersect with viral oncoprotein activity in cervical cancer.
Researchers can employ HDAC8 Knockout Ca Ski Polyclonal Cells in a diverse array of experimental applications. Typical studies include oncogenic signaling investigation via western blotting and RNA-seq, epigenetic profiling by ChIP-qPCR, and apoptosis assays to assess cell death sensitivity. Functional analyses are well-suited for migration and invasion assays, and the model is ideal for drug sensitivity screening of HDAC inhibitors in conjunction with HPV oncogene interaction studies. Flow cytometry further enables cell cycle and apoptotic population analyses. For additional details or to discuss custom projects, please contact Ascent Research.
